Related Experiment Video
Updated: May 22, 2026
09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
[SIADH and vaptans]
1Service de médecine interne générale, hôpital universitaire Erasme, Bruxelles, Belgique. guy.decaux@skynet.be
Annales D'Endocrinologie
|April 28, 2012
Summary
Vaptans, including tolvaptan, are new treatments for Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH)-related hyponatremia. Their role is compared to established therapies like water restriction and diuretics.
Area of Science:
- Pharmacology
- Nephrology
- Endocrinology
Background:
- Arginine-vasopressin receptor antagonists, known as vaptans, represent a novel class of therapeutics.
- These agents are pharmacologically active via oral and intravenous administration routes.
- Clinical development has led to market approval for select vaptans.
Purpose of the Study:
- To evaluate the therapeutic positioning of tolvaptan for hyponatremia secondary to SIADH within the European Union.
- To compare the efficacy and application of tolvaptan against existing treatments for SIADH.
Main Methods:
- Review of clinical development data for vaptan therapies.
- Comparative analysis of tolvaptan's clinical profile against water restriction, demeclocyclocycline, furosemide, and urea.
- Assessment of market authorization status in the EU.
Main Results:
- Tolvaptan is the only vaptan approved in the EU for treating hyponatremia associated with SIADH.
- The study delineates the comparative therapeutic landscape for SIADH management.
Conclusions:
- Tolvaptan offers a new pharmacological option for SIADH-related hyponatremia in the EU.
- Its clinical utility is defined in relation to conventional therapeutic strategies.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:18Additional Routes of Drug Administration
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...